BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 8800972)

  • 1. Stability of epinephrine hydrochloride in an extemporaneously compounded topical anesthetic solution of lidocaine, racepinephrine, and tetracaine.
    Larson TA; Uden DL; Schilling CG
    Am J Health Syst Pharm; 1996 Mar; 53(6):659-62. PubMed ID: 8800972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of milrinone and epinephrine, atropine sulfate, lidocaine hydrochloride, or morphine sulfate injection.
    Wilson TD; Forde MD
    Am J Hosp Pharm; 1990 Nov; 47(11):2504-7. PubMed ID: 2278262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of flucytosine in an extemporaneously compounded oral liquid.
    Wintermeyer SM; Nahata MC
    Am J Health Syst Pharm; 1996 Feb; 53(4):407-9. PubMed ID: 8673661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lidocaine stability in cardioplegic solution stored in glass bottles and polyvinyl chloride bags.
    Lackner TE; Baldus D; Butler CD; Amyx C; Kessler G
    Am J Hosp Pharm; 1983 Jan; 40(1):97-101. PubMed ID: 6823998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physico-chemical stability of infusion solutions for epidural administration containing fentanyl and bupivacaine or lidocaine.
    Sattler A; Jage J; Krämer I
    Pharmazie; 1998 Jun; 53(6):386-91. PubMed ID: 9675768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of frozen 1% voriconazole eye-drops in both glass and innovative containers.
    Roche M; Lannoy D; Bourdon F; Danel C; Labalette P; Berneron C; Simon N; Odou P
    Eur J Pharm Sci; 2020 Jan; 141():105102. PubMed ID: 31655210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of extemporaneously compounded temozolomide 10 mg/mL suspensions in Oral Mix SF® in glass and plastic bottles and plastic syringes.
    Lingertat-Walsh K; Weilnau J; Cober MP; Ostrenga A; Poon B; Sales P; Law S; Dupuis LL; Walker SE
    J Oncol Pharm Pract; 2021 Jan; 27(1):78-87. PubMed ID: 32228132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of terminal sterilization by irradiation on amber Type I and Type III glass containers containing veterinary oxytetracycline suspension.
    Wong J; Papadopoulos P; Rebbeck C; Schwabe S; Lischewski G; Melchert J; Kuu W; Agostinelli T; Smith T; Brame G; Lynn R; Hepler D
    PDA J Pharm Sci Technol; 2004; 58(1):6-14. PubMed ID: 15053050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of nifedipine in an extemporaneously compounded oral solution.
    Dentinger PJ; Swenson CF; Anaizi NH
    Am J Health Syst Pharm; 2003 May; 60(10):1019-22. PubMed ID: 12789873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of Extemporaneously Compounded Nadolol 10-mg/mL Suspension in Oral Mix in Glass and Plastic Bottles and Plastic Syringes.
    Walsh A; Ziegler B; Lingertat-Walsh K; Law S; Walker SE
    Int J Pharm Compd; 2021; 25(2):163-168. PubMed ID: 33798116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodestabilization of epinephrine by sodium metabisulfite.
    Brustugun J; Tønnesen HH; Klem W; Kjønniksen I
    PDA J Pharm Sci Technol; 2000; 54(2):136-43. PubMed ID: 10822984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buffered lidocaine hydrochloride solution with and without epinephrine: stability in polypropylene syringes.
    Pascuet E; Donnelly RF; Garceau D; Vaillancourt R
    Can J Hosp Pharm; 2009 Sep; 62(5):375-80. PubMed ID: 22478919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers.
    Taormina D; Abdallah HY; Venkataramanan R; Logue L; Burckart GJ; Ptachcinski RJ; Todo S; Fung JJ; Starzl TE
    Am J Hosp Pharm; 1992 Jan; 49(1):119-22. PubMed ID: 1373936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term Stability of Cocaine Hydrochloride Aqueous Solution 50 mg/mL (5%) at Room Temperature and at 5°C ± 3°C in Glass Bottles.
    Dewulf J; Hecq JD; Huvelle S; Godet M; Gillet P; Jamart J; Galanti LM
    Int J Pharm Compd; 2015; 19(3):268-70. PubMed ID: 26714368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of famotidine in an extemporaneously prepared oral liquid.
    Quercia RA; Jay GT; Fan C; Chow MS
    Am J Hosp Pharm; 1993 Apr; 50(4):691-3. PubMed ID: 8470686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of an extemporaneously compounded clonidine hydrochloride oral liquid.
    Levinson ML; Johnson CE
    Am J Hosp Pharm; 1992 Jan; 49(1):122-5. PubMed ID: 1570852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride.
    Wu G; Yeung S; Chen F
    Int J Pharm Compd; 2017; 21(1):76-82. PubMed ID: 28346200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of carboplatin in 5% glucose solution in glass, polyethylene and polypropylene containers.
    Prat J; Pujol M; Girona V; Muñoz M; Solé LA
    J Pharm Biomed Anal; 1994 Jan; 12(1):81-4. PubMed ID: 8161609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of fosphenytoin sodium with intravenous solutions in glass bottles, polyvinyl chloride bags, and polypropylene syringes.
    Fischer JH; Cwik MJ; Luer MS; Sibley CB; Deyo KL
    Ann Pharmacother; 1997 May; 31(5):553-9. PubMed ID: 9161647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of an extemporaneously compounded levothyroxine sodium oral liquid.
    Boulton DW; Fawcett JP; Woods DJ
    Am J Health Syst Pharm; 1996 May; 53(10):1157-61. PubMed ID: 8734676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.